Client: Dechra Mirataz launch

Task: To launch Mirataz to the UK and Ireland veterinary market and raise awareness of the first and only veterinary licensed mirtazapine

Campaign context: The new product, Mirataz®, is the first and only licensed transdermal mirtazapine ointment for cats and is a medication for body weight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions.

Challenge: There are alternatives to Mirataz – a tablet which is for human use and two veterinary ‘specials’ that are made to order. Getting the Vets out of existing habits, and select the new solution of Mirataz by educating and engaging, plus raising awareness of the first and only veterinary licensed mirtazapine

Solution: